Home » Topics » Regulatory » Patents

Patents
RSS

New phenylpropionic acid derivatives with excellent antidiabetic effects

April 27, 1999

Another series of HDL-increasing compounds revealed by American Home Products

April 27, 1999

Agents with affinity for dopamine and 5-HT1A receptors in development at Duphar

April 26, 1999

Coumarin derivatives with antiviral activity against HIV from Pliva

April 26, 1999

Lilly develops new antioxidants with particular utility as neuroprotectants

April 26, 1999

SS Pharm. presents new AGE inhibitors for use in diabetic complications

April 26, 1999

Selective 5-HT1A ligands described by ADIR in recent patent

April 26, 1999

BASF claims series with mixed ETA/ETB-antagonist properties

April 26, 1999

HDL-increasing compounds claimed by AHP for cardiovascular disease, dyslipoproteinemia

April 26, 1999

Hybridon describes mixed-backbone anti-MDM2 antisense oligonucleotide active in vivo

April 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...